Literature DB >> 26338309

Risk factors for concurrent bacteremia in adult patients with dengue.

Tun-Linn Thein1, Ee-Ling Ng2, Ming S Yeang3, Yee-Sin Leo4, David C Lye5.   

Abstract

BACKGROUND/
PURPOSE: Bacteremia in dengue may occur with common exposure to pathogens in association with severe organ impairment or severe dengue, which may result in death. Cohort studies identifying risk factors for concurrent bacteremia among patients with dengue are rare.
METHODS: We conducted a retrospective case-control study of adult patients with dengue who were admitted to the Department of Infectious Diseases at Tan Tock Seng Hospital, Singapore from 2004 to 2008. For each case of dengue with concurrent bacteremia (within the first 72 hours of admission), we selected four controls without bacteremia, who were matched on year of infection and dengue confirmation method. Conditional logistic regression was performed to identify risk factors for concurrent bacteremia.
RESULTS: Among 9,553 patients with dengue, 29 (0.3%) had bacteremia. Eighteen of these patients (62.1%) had concurrent bacteremia. The predominant bacteria were Staphylococcus aureus, one of which was a methicillin-resistant strain. Dengue shock syndrome occurred more frequently and hospital stay was longer among cases than among controls. Three cases did not survive, whereas none of the controls died. In multivariate analysis, being critically ill at hospital presentation was independently associated with 15 times the likelihood of a patient with dengue having concurrent bacteremia.
CONCLUSION: Concurrent bacteremia in adult patients with dengue is uncommon but presents atypically and results in more deaths and longer hospital stay. Given the associated mortality, collection of blood cultures and empiric antibiotic therapy may be considered in patients who are critically ill.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Adult; Concurrent bacteremia; Dengue; Mortality; Severity; Singapore

Mesh:

Year:  2015        PMID: 26338309     DOI: 10.1016/j.jmii.2015.06.008

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  9 in total

Review 1.  Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern.

Authors:  Mattia Trunfio; Alessia Savoldi; Ottavia Viganò; Antonella d'Arminio Monforte
Journal:  Infection       Date:  2016-07-22       Impact factor: 3.553

2.  The exploration of risk factors of concurrent bacteraemia in patients critically ill with severe dengue.

Authors:  Chin-Ming Chen; Khee-Siang Chan; Kuo-Chen Cheng; Willy Chou; Hui-Chun Chao; Chiu-Yin Yeh; Wen-Liang Yu
Journal:  J Med Microbiol       Date:  2016-11-07       Impact factor: 2.472

3.  Concurrent methicillin-resistant Staphylococcus aureus septicemia and pyomyositis in a patient with dengue hemorrhagic fever: a case report.

Authors:  N D B Ehelepola; R K G M Rajapaksha; D M U B Dhanapala; T D K Thennekoon; S Ponnamperuma
Journal:  BMC Infect Dis       Date:  2018-02-27       Impact factor: 3.090

4.  Culture-positive unilateral panophthalmitis in a serology-positive case of dengue hemorrhagic fever.

Authors:  Richa Kamal; Dhaivat Shah; Satish Sharma; Madharuvasal Krishnan Janani; Arindam Kar; Kumar Saurabh; Rupak Roy; Hajib Narahari Rao Madhavan
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

5.  Dynamic changes of soluble ST2 levels predicted fatality and were involved in coagulopathy in dengue fever in the elderly.

Authors:  Chih-Cheng Hsieh; Ming-Yuan Hong; Tzong-Shiann Ho; Ching-Chuan Liu; Guey-Chuen Perng; Chia-Chang Chuang
Journal:  PLoS Negl Trop Dis       Date:  2019-12-26

Review 6.  Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development.

Authors:  Kulkanya Chokephaibulkit; Yu-Wen Chien; Sazaly AbuBakar; Kovit Pattanapanyasat; Guey Chuen Perng
Journal:  Viruses       Date:  2020-11-05       Impact factor: 5.048

7.  The characteristics of bacteremia among patients with acute febrile illness requiring hospitalization in Indonesia.

Authors:  Pratiwi Soedarmono; Aly Diana; Patricia Tauran; Dewi Lokida; Abu Tholib Aman; Bachti Alisjahbana; Dona Arlinda; Emiliana Tjitra; Herman Kosasih; Ketut Tuti Parwati Merati; Mansyur Arif; Muhammad Hussein Gasem; Nugroho Harry Susanto; Nurhayati Lukman; Retna Indah Sugiyono; Usman Hadi; Vivi Lisdawati; Karine G Fouth Tchos; Aaron Neal; Muhammad Karyana
Journal:  PLoS One       Date:  2022-09-08       Impact factor: 3.752

8.  Management and outcomes of severe dengue patients presenting with sepsis in a tropical country.

Authors:  Prapit Teparrukkul; Viriya Hantrakun; Nicholas P J Day; T Eoin West; Direk Limmathurotsakul
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

9.  Prognostic Factors in Adult Patients with Dengue: Developing Risk Scoring Models and Emphasizing Factors Associated with Death ≤7 Days after Illness Onset and ≤3 Days after Presentation.

Authors:  Ing-Kit Lee; Chung-Hao Huang; Wen-Chi Huang; Yi-Chun Chen; Ching-Yen Tsai; Ko Chang; Yen-Hsu Chen
Journal:  J Clin Med       Date:  2018-10-28       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.